HMGB1 and cancer: Here, we tested the hallmarks of ICD in IR-780 treated cancer cells and observed dose-dependent increases in ATP and HMGB1 secretion, as well as the expression of the ER/cytosolic chaperone, CRT, on the surface of cancer cells (Figure 2A).